Viking Therapeutics, Inc.
USD40.97
+1.43 (+3.62%)
CEO
Brian Lian
IPO Date
2015-04-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$39.50
Prev. Close
$39.54
Day Low
$39.08
Day High
$41.40
52W Low
$22.96
52W High
$43.15
Market Cap
$4.76B
Volume
1.64M
| 0 |
| $0.00 |
| 10 Mar 2026 | Aubuchon Neil William | Chief Commercial Officer | P-Purchase | Acquired | 4,475 | $33.50 |
| 26 Jan 2026 | Aubuchon Neil William | Chief Commercial Officer | A-Award | Acquired | 180,000 | $31.76 |
| 26 Jan 2026 | Aubuchon Neil William | — | Disposed | 0 | $0.00 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | A-Award | Acquired | 41,000 | $0.00 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | A-Award | Acquired | 32,049 | $0.00 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | S-Sale | Disposed | 31,961 | $32.30 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | S-Sale | Disposed | 13,900 | $33.38 |
| 5 Jan 2026 | ZANTE GREG | Chief Financial Officer | S-Sale | Disposed | 10,300 | $34.24 |